Related Experiment Video
Updated: May 29, 2025
06:08
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
1.1K
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant
Mehul S Suthar1, Kelly E Manning2, Madison L Ellis2
1Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA; Emory Vaccine Center, Emory University, Atlanta, GA, USA; Emory National Primate Research Center, Atlanta, GA, USA; Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA.
The Lancet. Infectious Diseases
|February 3, 2025
Abstract
No abstract available in PubMed .
